Fig. 6From: Identifying an early treatment window for predicting breast cancer response to neoadjuvant chemotherapy using immunohistopathology and hemoglobin parametersROC curves of testing data of four groups of prediction models based on a HER2 subtype and hemoglobin parameters, b ER subtype and hemoglobin parameters, c TN subtype and hemoglobin parameters, and d hemoglobin parametersBack to article page